Schedule 13G ownership disclosure
Relay Therapeutics Inc
Common Stock, par value $0.0001 per share · CUSIP: 75943R102
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Commodore Capital LP
Shares: 13,350,000.00 · Class: 7.8%
- Commodore Capital Master LP
Shares: 13,350,000.00 · Class: 7.8%
- Robert Egen Atkinson
Shares: 13,350,000.00 · Class: 7.8%
- Michael Kramarz
Shares: 13,350,000.00 · Class: 7.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001831942-25-000014
- Form type
- SCHEDULE 13G/A
- Filer
- Commodore Capital LP
- CIK
- CIK 1831942
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership